EASY BIO,Inc. (KOSDAQ:353810)
South Korea · Delayed Price · Currency is KRW 7,000.00
-200.00 (-2.78%)
May 21, 2026, 12:00 PM KST
EASY BIO,Inc. Market Cap
EASY BIO,Inc. has a market cap or net worth of 238.19 billion as of May 20, 2026. Its market cap has increased by 35.59% in one year.
Market Cap
238.19B
Enterprise Value
334.96B
Revenue
476.94B
Ranking
n/a
PE Ratio
8.57
Stock Price
7,000.00
Market Cap Chart
Since June 5, 2020, EASY BIO,Inc.'s market cap has increased from 34.76B to 238.19B, an increase of 585.28%. That is a compound annual growth rate of 38.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 238.19B | 23.92% |
| Dec 30, 2025 | 192.21B | 37.78% |
| Dec 30, 2024 | 139.50B | 12.89% |
| Dec 28, 2023 | 123.58B | -10.06% |
| Dec 29, 2022 | 137.40B | -14.99% |
| Dec 30, 2021 | 161.64B | -23.75% |
| Dec 18, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 331.48B |
| Helixmith | 320.03B |
| Anterogen.Co.,Ltd. | 305.69B |
| GC Cell | 297.09B |
| BINEX | 287.90B |
| HLB Therapeutics | 270.75B |
| Bioneer | 259.39B |
| NeoImmuneTech | 247.66B |